18 reports

  • Hypothyroidism Trial Snapshots- 2013
  • Hypothyroidism Trial Snapshots- 2013
  • Endocrine Disease
  • World
  • Company Operations
  • Product Initiative
  • GlaxoSmithKline plc
  • APR 26, 2017: SHIRE GRANTED EU CONDITIONAL MARKETING AUTHORISATION FOR NATPAR (PARATHYROID HORMONE) FOR THE TREATMENT OF PATIENTS WITH CHRONIC HYPOPARATHYROIDISM
  • MAY 19, 2017: SHIRE TO HIGHLIGHT NEW RESEARCH INTO CHRONIC HYPOPARATHYROIDISM AT THE EUROPEAN CONGRESS OF ENDOCRINOLOGY

Hypoparathyroidism is a rare endocrine disease resulting from an inappropriately low circulating PTH concentration.

  • Endocrine Disease
  • Therapy
  • Europe
  • United States
  • NPS Pharmaceuticals, Inc.
  • APR 26, 2017: SHIRE GRANTED EU CONDITIONAL MARKETING AUTHORISATION FOR NATPAR (PARATHYROID HORMONE) FOR THE TREATMENT OF PATIENTS WITH CHRONIC HYPOPARATHYROIDISM

Hypoparathyroidism is a rare endocrine disease resulting from an inappropriately low circulating PTH concentration.

  • Endocrine Disease
  • Therapy
  • United States
  • World
  • NPS Pharmaceuticals, Inc.

This agreement enables PeptiDream and Ipsen to discover, develop and commercialize therapeutic peptides to treat serious Endocrine diseases.

  • Blood Disease
  • Endocrine Disease
  • United States
  • Demand
  • Ipsen S.A.
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database
  • Endocrine Disease
  • Pathology
  • World
  • Product Initiative
  • Uni-Pharma SA
  • Hyperthyroidism Trial Snapshots- 2012

Auto-immune disorder including Graves' disease is the common cause of the condition.

  • Drug Discovery And Development
  • Endocrine Disease
  • World
  • Company Operations
  • Product Initiative
  • Mar 09, 2016: XOMA Reports Fourth Quarter and Full-Year 2015 Financial Results

" With our strategic focus on advancing our endocrine programs, we continue to seek ways to support and fund these efforts through discovery and licensing of our non-endocrine assets.

  • Endocrine Disease
  • Pharmaceutical
  • United States
  • Company
  • XOMA Corporation

There are currently no approved therapies for PCOS, which is the most common endocrine disease in women.

  • Endocrine Disease
  • Therapy
  • United States
  • World
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Cardiometabolic Disease Global Clinical Trials Review, H##, 2017 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: MAY 2017 LIST OF TABLES LIST OF FIGURES CARDIOMETABOLIC DISEASE GLOBAL CLINICAL TRIALS REVIEW, H##, 2017 OUTLINES CLINICAL TRIALS IN CARDIOMETAB

  • Endocrine Disease
  • Pathology
  • World
  • Product Initiative
  • EFFRX PHARMACEUTICALS SA
  • POLYCYSTIC OVARIAN SYNDROME - PIPELINE BY BAYER AG, H2 2017
  • Endocrine Disease
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

a science-driven biopharmaceutical company that is committed to developing innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases, announced that additional positive results from the Phase ## ACTIVE (Abaloparatide Comparator Trial In Vertebral Endpo

  • Endocrine Disease
  • Hormone
  • Musculoskeletal Disorder
  • Therapy
  • World

" This program represents a significant extension of Crinetics' efforts to develop drugs that target endocrine diseases and endocrine related cancers.

  • Endocrine Disease
  • Pharmaceutical
  • Therapy
  • World
  • Crinetics Pharmaceuticals, Inc.
  • XOMA Corporation - Company Statement

Our business efforts are focused on advancing the assets in our portfolio of compounds that could treat a variety of endocrine diseases.

  • Endocrine Disease
  • United States
  • World
  • Product Initiative
  • XOMA Corporation
  • 4.1 DISEASE BACKGROUND

ENDOCRINE PRACTICE; ##(##): ##-##.

  • Endocrine Disease
  • Forecast
  • Amgen Inc.
  • Keryx Biopharmaceuticals, Inc.
  • OPKO Health, Inc.
  • 2.1 DISEASE BACKGROUND

Endocrine Connections; ##(##): ##-##.

  • Endocrine Disease
  • Japan
  • United Kingdom
  • United States
  • Forecast

FRAX is a registered trademark of The Centre for Metabolic Bone Diseases at the University of Sheffield.

  • Endocrine Disease
  • Hormone
  • Musculoskeletal Disorder
  • Therapy
  • World

ENDOCRINE HORMONES: THE PRODUCTS SECRETED BY THE ENDOCRINE GLANDS.

  • Endocrine Disease
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited

Jiangsu Hengrui' s research and development activities focus on developing novel medicines in areas of cardiovascular, antineoplastics, endocrine system and the immune system.

  • Cardiovascular Disease
  • Chronic Disease
  • Endocrine Disease
  • United States
  • Product Initiative